Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
09/2011
09/07/2011CN101580497B Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof
09/01/2011WO2011104680A1 Oxadiazole compounds, their preparation and use
09/01/2011WO2011104671A1 Novel water soluble furoxan derivatives having antitumor activity
09/01/2011WO2011104203A1 Compounds as bradykinin b1 antagonists
09/01/2011CA2791162A1 Oxadiazole compounds, their preparation and use
09/01/2011CA2790952A1 Compounds as bradykinin b1 antagonists
08/2011
08/31/2011CN102171190A Insecticidal benzenedicarboxamide derivative
08/31/2011CN101891697B Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle
08/31/2011CN101648922B Benzamide histone deacetylase inhibitor and application thereof
08/30/2011US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis
08/25/2011US20110207936 Method for producing oxadiazolinone compound and intermediate thereof
08/25/2011US20110207935 Fused-ring derivative and medical application of same
08/25/2011US20110207784 Oxadiazole-2-oxides as antischistosomal agents
08/25/2011US20110207704 Novel Oxadiazole Compounds
08/24/2011EP2358656A2 Spirocyclic gpr40 modulators
08/24/2011CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
08/24/2011CN102161646A Stilbene derivative with 1,3,4-oxadiazole and preparation method and application thereof
08/24/2011CN101851215B Method for catalyzing and synthesizing 3,4-dinitrofurazan by utilizing1-butyl-3-methylimidazole tungstate
08/24/2011CN101218214B Liquid crystal compound, liquid crystal composition, thin film, and liquid crystal display
08/23/2011US8003800 Thiophene derivatives as S1P1/EDG1 receptor agonists
08/23/2011US8003676 1,3,4-oxadiazole derivatives as DGAT1 inhibitors
08/23/2011US8003675 3,4-dihalogenoisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
08/23/2011US8003648 Heterocyclic GPR40 modulators
08/17/2011EP2357167A1 Method for producing oxadiazolinone compound and intermediate thereof
08/17/2011EP1670772B1 Derivatives of 1,3-diones having a herbicidal activity
08/17/2011CN1913886B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/17/2011CN1910156B Malononitrile compound as pesticide
08/11/2011WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
08/11/2011US20110196002 Diacylglycerol acyltransferase inhibitors
08/04/2011WO2011092611A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
08/04/2011US20110190205 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
08/04/2011CA2786688A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
08/03/2011EP2350067A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/02/2011US7989498 Inhibitors of IMPDH enzyme
07/2011
07/26/2011US7985761 Diphenylurea derivatives and their use as chloride channel blockers or BKCa channel modulators
07/21/2011US20110178133 Calcium receptor modulating agents
07/21/2011US20110178087 Compositions and Their Use as Anti-Tumor Agents
07/21/2011US20110178056 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
07/19/2011US7982047 Derivatives of 1,3-diones having a herbicidal activity
07/19/2011US7981910 Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
07/19/2011CA2420279C Selective androgen receptor modulators and methods of use thereof
07/14/2011WO2011085406A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
07/14/2011US20110172278 Compounds and methods for modulating g protein-coupled receptors
07/14/2011US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
07/14/2011US20110171172 Compounds for inhibiting ksp kinesin activity
07/14/2011CA2786716A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
07/13/2011EP2343069A1 Heterocyclic aspartyl protease inhibitors
07/13/2011EP2342177A1 Novel potassium channel blockers
07/13/2011CN101190917B 3,4-dihydro-3-methyl-4-oxomidazo[5,1-d]-1,2,3,5-tetrazine-8-formic acid benzenesulfonyl furoxan esters compound, preparation method and use thereof
07/12/2011US7977491 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
07/12/2011US7977362 Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
07/12/2011US7977322 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/06/2011CN1867554B Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
07/05/2011US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
07/05/2011CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
07/05/2011CA2446136C Pyruvate derivatives
06/2011
06/30/2011US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/29/2011EP2338886A2 Naphthalene derivatives
06/28/2011US7968552 Oxadiazolidinedione compound
06/28/2011US7968157 Discotic nematic material, composition, retardation plate, elliptically-polarizing plate and compound
06/28/2011US7968156 Compound, composition, retardation plate, elliptically-polarizing plate and liquid-crystal display device
06/28/2011CA2635196C Glucocorticoid receptor modulators
06/28/2011CA2427206C Sulfamides as gamma-secretase inhibitors
06/23/2011US20110152295 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/23/2011US20110152232 Sulfonamide compounds and uses thereof
06/23/2011US20110152084 N-(1,2,5-oxadiazol-3-yl)benzamides and their use as herbicides
06/22/2011EP2335701A1 Heterocyclic aspartyl protease inhibitors
06/22/2011CN101175736B Compound, composition, phase difference plate, elliptically polarizing plate and liquid crystal display device
06/21/2011CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/16/2011US20110144066 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
06/16/2011US20110139654 Oxadiazole derivatives for the treatment of diabetes
06/15/2011CN102093232A Trifluoreneamine compound, trifluoreneamine polymer luminescent material and preparation methods and application thereof
06/14/2011US7960544 Useful indole compounds
06/14/2011CA2456235C Heterocyclylarylsulphonamides
06/08/2011CN102089297A Novel 1,2,4 oxadiazole compounds and methods of use thereof
06/08/2011CN102088855A 2-aryl glycinamide derivatives
06/08/2011CN102086177A Method for preparing 4-(3-(4-hydroxylphenyl)-1,2,4-oxadiazole-5-yl)-aniline
06/07/2011US7956074 Aryl-isoxazolo-4-yl-oxadiazole derivatives
06/07/2011US7956054 Dual-acting pyrazole antihypertensive agents
06/07/2011CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors
06/01/2011CN102079730A Derivatives containing 2, 5-substituted heterocyclic radical sulphone and synthesis method and application thereof
06/01/2011CN102079729A Compounds with antiparasitic activity and medicaments containing them
05/2011
05/25/2011EP2323656A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
05/25/2011EP2323655A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102076670A Compounds and methods for modulating g protein-coupled receptors
05/24/2011US7947841 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
05/19/2011CA2780772A1 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
05/19/2011CA2780433A1 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
05/18/2011EP2321862A1 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same
05/18/2011CN101460470B 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
05/12/2011WO2011056841A1 A facile synthesis of 3-aminopicric acid
05/12/2011WO2010151672A3 Amino acid derived ureas
05/12/2011US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/11/2011EP2318374A2 Insecticidal benzenedicarboxamide derivative
05/11/2011CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/11/2011CN102056894A Homocysteine synthase inhibitor
05/05/2011US20110106241 Compositions and methods for inhibiting sphingosine kinase
05/05/2011US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
05/05/2011US20110105532 Haloalkyl-substituted amides as insecticides and acaricides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 72